Skip to content

Clinical trials

Observational Small Cell Lung Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Observational Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20161
20173
20191
20203
20222
20233
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Unknown status8
Completed5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
Shanghai Chest Hospital2
Anhui Shi, MD1
Bai Chunxue1
Bristol-Myers Squibb1
Chinese Academy of Medical Sciences1
Creative Biosciences (Guangzhou) Co., Ltd.1
Guangdong Association of Clinical Trials1
Henan Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma24
Lung Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Adenocarcinoma1
Adenocarcinoma of Lung1
Bronchitis1
Bronchitis, Chronic1
Carcinoma1
Carcinoma, Adenosquamous1
Carcinoma, Large Cell1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.